BPTHOTCPharmaceutical PreparationsFiscal year ends December 31
BIO-PATH HOLDINGS, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.80K
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Bio-Path has not reported a dividend
No dividend per share appears in Bio-Path's annual filings since fiscal 2010.